Skip to content

Anti-Vascular Endothelial Growth Factor in Retinopathy of Prematurity Management: A survey practice in Thailand

Anti-Vascular Endothelial Growth Factor in Retinopathy of Prematurity Management: A survey practice in Thailand

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20260317001
Enrollment
261
Registered
2026-03-17
Start date
2023-11-04
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

current practices patterns of anti-VEGF therapy in the management of ROP among Ophthalmologists in Thailand Anti-VEGF retinopathy of prematurity Thailand survey

Interventions

The members of the Royal College of Ophthalmologists of Thailand (RCOPT), Thai Pediatric Ophthalmology and Strabismus Specialists, and Thai Retina and Vitreous Specialists groups. These groups were id
Health Services Research
Respondents

Sponsors

Khonkaen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Members of the Royal College of Ophthalmologists of Thailand 2. Members of Thai Pediatric Ophthalmology and Strabismus Society 3. Members of Thai Retina Society

Exclusion criteria

Exclusion criteria: 1. Not Member of the Royal College of Ophthalmologists of Thailand

Design outcomes

Primary

MeasureTime frame
Dosage use November 4th, 2023, to July 10th, 2024. Survey

Secondary

MeasureTime frame
Age of respondent November 4th, 2023, to July 10th, 2024. Survey,Field of subspecialty November 4th, 2023, to July 10th, 2024. Survey,Place of work November 4th, 2023, to July 10th, 2024. Survey,Use of Anti-VEGF in ROP November 4th, 2023, to July 10th, 2024. Survey,Number of ROP case(s) treat with anti-VEGF per month November 4th, 2023, to July 10th, 2024. survey,Indication(s) of treatment November 4th, 2023, to July 10th, 2024. Survey,preferred anti-VEGF agent November 4th, 2023, to July 10th, 2024. survey,Location for treatment November 4th, 2023, to July 10th, 2024. survey,Type of anesthesia November 4th, 2023, to July 10th, 2024. survey,Follow up protocol after first injection November 4th, 2023, to July 10th, 2024. survey,The need of guideline treatment for anti-VEGF in ROP November 4th, 2023, to July 10th, 2024. survey,Next follow up protocol November 4th, 2023, to July 10th, 2024. survey,Second treatment if failed anti-VEGF November 4th, 2023, to July 10th, 2024. survey,Acceptable number of repeat anti-VEGF injection November 4th, 2023, to July 10th, 2024. survey,Gender of respondent November 4th, 2023, to July 10th, 2024. survey

Countries

Thailand

Contacts

Public ContactWorranittha Angkanupong

Faculty of Medicine, Khon Kaen University

worra.ang@gmail.com0836368003

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026